These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25794600)

  • 21. A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials.
    Chen SC; Kim SY
    Clin Trials; 2016 Dec; 13(6):605-611. PubMed ID: 27365010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey.
    Nayak RK; Wendler D; Miller FG; Kim SY
    Ann Intern Med; 2015 Sep; 163(5):356-64. PubMed ID: 26215125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Targeted" consent for pragmatic clinical trials.
    Wendler D
    J Gen Intern Med; 2015 May; 30(5):679-82. PubMed ID: 25586870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Ethical Analysis of the SUPPORT Trial: Addressing Challenges Posed by a Pragmatic Comparative Effectiveness Randomized Controlled Trial.
    Horn AR; Weijer C; Grimshaw J; Brehaut J; Fergusson D; Goldstein CE; Taljaard M
    Kennedy Inst Ethics J; 2018; 28(1):85-118. PubMed ID: 29628452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low risk pragmatic trials do not always require participants' informed consent.
    Dal-Ré R; Avendaño-Solà C; Bloechl-Daum B; de Boer A; Eriksson S; Fuhr U; Holm S; James SK; Mentz RJ; Perucca E; Rosendaal FR; Treweek S
    BMJ; 2019 Mar; 364():l1092. PubMed ID: 30917969
    [No Abstract]   [Full Text] [Related]  

  • 27. Informed consent for comparative effectiveness trials.
    Faden RR; Beauchamp TL; Kass NE
    N Engl J Med; 2014 May; 370(20):1959-60. PubMed ID: 24827051
    [No Abstract]   [Full Text] [Related]  

  • 28. Informed consent for comparative effectiveness trials.
    Anderson JR; Schonfeld TL
    N Engl J Med; 2014 May; 370(20):1958. PubMed ID: 24827052
    [No Abstract]   [Full Text] [Related]  

  • 29. Informed consent for comparative effectiveness trials.
    Schreiner MS
    N Engl J Med; 2014 May; 370(20):1958. PubMed ID: 24827053
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.
    Anderson ML; Califf RM; Sugarman J;
    Clin Trials; 2015 Jun; 12(3):276-86. PubMed ID: 25733677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
    Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
    Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informed consent for pragmatic trials--the integrated consent model.
    Kim SY; Miller FG
    N Engl J Med; 2014 Feb; 370(8):769-72. PubMed ID: 24552326
    [No Abstract]   [Full Text] [Related]  

  • 33. Brief Report: Staged-informed Consent in the Cohort Multiple Randomized Controlled Trial Design.
    Young-Afat DA; Verkooijen HA; van Gils CH; van der Velden JM; Burbach JP; Elias SG; van Delden JJ; Relton C; van Vulpen M; van der Graaf R
    Epidemiology; 2016 May; 27(3):389-92. PubMed ID: 27035689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Informed consent for comparative effectiveness trials.
    Williams RT
    N Engl J Med; 2014 May; 370(20):1959. PubMed ID: 24827056
    [No Abstract]   [Full Text] [Related]  

  • 35. Waivers and Alterations to Consent in Pragmatic Clinical Trials: Respecting the Principle of Respect for Persons.
    Kim SY; Miller FG
    IRB; 2016; 38(1):1-5. PubMed ID: 26964403
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Approaches for Notification and Authorization in Pragmatic Clinical Research Evaluating Commonly Used Medical Practices.
    Weinfurt KP; Bollinger JM; Brelsford KM; Bresciani M; Lampron Z; Lin L; Topazian RJ; Sugarman J
    Med Care; 2017 Nov; 55(11):970-978. PubMed ID: 28650924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethics and Regulatory Challenges and Opportunities in Patient-Centered Comparative Effectiveness Research.
    Sugarman J
    Acad Med; 2016 Apr; 91(4):455-7. PubMed ID: 26826074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do doctors have a duty to take part in pragmatic randomised trials?
    Campbell MK; Weijer C; Goldstein CE; Edwards SJL
    BMJ; 2017 Jun; 357():j2817. PubMed ID: 28615179
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of altered informed consent in pragmatic clinical research.
    McKinney RE; Beskow LM; Ford DE; Lantos JD; McCall J; Patrick-Lake B; Pletcher MJ; Rath B; Schmidt H; Weinfurt K
    Clin Trials; 2015 Oct; 12(5):494-502. PubMed ID: 26374677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.